Clarity on vascular damage in brain scans

As people age, vascular damage often occurs in the brain. Researchers from UMC Utrecht and Erasmus MC have now developed reference values for this type of damage. These new standards help doctors objectively determine whether changes observed on brain scans are normal for a person’s age and gender or if they deviate from the norm. The researchers have published their findings in two scientific articles.
Reference values are important in healthcare and are often used to interpret research results. “When you take your child to a health clinic, they measure height and weight and compare that to growth charts,” says Prof. Geert Jan Biessels, neurologist at UMC Utrecht. “This allows you to immediately see what is normal and what is not. But in hospitals, brain scans are still largely evaluated by eye. This is subjective, and it often remains unclear whether, for example, vascular damage or shrinkage is appropriate for a patient’s age. As a result, many people are unnecessarily alarmed by their scan results.”
Vascular damage and aging
Even if they have never had a stroke, elderly individuals often have mild vascular damage visible on brain scans. This damage can become severe enough to cause cognitive problems or balance issues. The role of vascular damage is often overlooked or recognized too late. Biessels explains: “Scans can show this damage early on, but without reference values, it can be difficult to properly assess the severity.”
The results presented by the researchers are based on data from two large research projects (see sidebar), to which multiple research groups contributed. In total, more than 20,000 brain scans from thousands of participants were analyzed. These efforts produced detailed charts showing the normal values for different forms of vascular damage by age group and gender, similar to the growth charts used in health clinics.
“These standards provide us as doctors with much more certainty,” says Prof. Meike Vernooij, neuroradiologist at Erasmus MC and involved in the studies. “We can now better determine if what we see on a scan is acceptable in the context of normal aging or if there is reason for further investigation.”
Reassuring patients
The new charts help doctors reassure patients when their scans fall within the expected range. They also offer opportunities for prevention and intervention. For example, doctors can advise patients with brain damage that may lead to stroke or cognitive decline to exercise more, better control their blood pressure and cholesterol, and stop smoking. “Although we cannot stop brain aging, we can limit further damage in some cases by addressing risk factors,” says Biessels.
The researchers expect the new standards to soon become part of clinical practice. In addition to better patient care, the data also contribute to further research into diseases such as dementia and stroke.
International collaboration
The new results come from two collaborative projects:
- The first project, which is part of the Dutch TAP-dementia program, involved researchers from Rotterdam and Utrecht. Using over 11,000 scans from thousands of participants across a wide age range, they mapped the main manifestations of aging-related vascular damage. This damage included white matter lesions (small damages in the connections between brain regions), lacunes (scars from small infarcts), microbleeds, and atrophy (brain shrinkage). Read the scientific article.
- In the second project, the team from Utrecht led a collaboration between 15 research groups worldwide to establish reference values for white matter lesions. Due to its international nature, with participants of various ages, genders, and ethnicities, scanned with different scanners, the study’s results are broadly applicable.
Read the scientific article.

Registration for Utrecht Science Week 2026 is now open: the knowledge festival at Utrecht Science Park
From Friday 25 September to Sunday 4 October, the sixth edition of Utrecht Science Week will take place. Utrecht Science Park will open its doors to everyone interested in (applied) science and innovation in the fields of life sciences, health, and sustainability.
The first programme elements have now been announced and registration is open. Many more events and activities will be added to the programme in the coming weeks.

New artificial heart implanted for the first time in Europe
Earlier this month at UMC Utrecht, a patient with advanced heart failure became the first person in Europe to receive a BrioVAD ventricular assist device. The new system is being evaluated in a European study and may offer advantages over the existing ventricular assist device. For UMC Utrecht, the implantation marks a new milestone in a long history of innovation in the field of mechanical circulatory support.

Successful first edition of Utrecht Life Sciences TechConnect
On 4 June 2026, researchers, technology experts, facility staff and innovation partners from across the Utrecht Life Sciences community gathered at Utrecht Science Park for the first edition of Utrecht Life Sciences TechConnect. The new annual event was created to strengthen connections between researchers and technology facilities, showcase advanced research technologies, and stimulate collaboration across disciplines.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals
On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).